JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL

Shifa Khaja Saleem(University of Freiburg), Christine Dierks(Genomics Institute of the Novartis Research Foundation)
The Journal of Experimental Medicine
November 21, 2024
Cited by 0


Related Papers